A62-15281-01115
2 vaccinations
6 coded responses
25 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 932 / CA
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 1 — Pfizer-BioNTech
- 2021-02-25
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-27
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis — Feeling: Poor · Site: PainFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: PoorFree text: Cold symptoms sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-03
-
2021-03-04
Survey response — day 7, dose 1MedDRA: Nasopharyngitis, Sinus disorder — Feeling: FairFree text: Cold and sinusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-30
- 2021-05-06
-
2021-06-24
Survey response — 3 months, dose 2MedDRA: Office visit, Sinus disorder — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Sinus problems · Healthcare visit (other): Actual appointmentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-26
-
2021-09-23
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Respiratory tract congestion, Sinus disorder — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sinus issues, breathing issues, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-03-25
Survey response — 12 months, dose 2MedDRA: Malaise — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Cold symptoms
Systemic reaction (other): Cold symptoms sore throat
Release 5 — day 7, dose 1
Systemic reaction (other): Cold and sinus
Release 9 — 3 months, dose 2
Release 9 — 6 months, dose 2
Symptoms: Sinus issues, breathing issues, congestion
Release 11 — 12 months, dose 2
Symptoms: Covid symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus disorder | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Sinus disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release